Article
The Use of Next-Generation Sequencing for the Quality Control of Live-Attenuated Polio Vaccines.
The Journal of infectious diseases - 9 Nov 2020
Charlton Bethany, Hockley Jason, Laassri Majid, Wilton Thomas, Crawt Laura, Preston Mark, Rigsby Peter, Chumakov Konstantin, Martin Javier
Abstract excerpt
BACKGROUND: Next-generation sequencing (NGS) analysis was compared to the current MAPREC (mutational analysis by polymerase chain reaction and restriction enzyme cleavage) assay for quality control of live-attenuated oral polio vaccine (OPV). METHODS: MAPREC measures reversion of the main OPV attenuating mutations such as uracil (U) to cytosine (C) at nucleotide 472 in the 5' noncoding region of type 3 OPV....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
